Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Pharmerica Corp Raises FY 2013 Guidance


Tuesday, 5 Nov 2013 08:00am EST 

Pharmerica Corp announced that for fiscal 2013, it expects revenue in the range of $1.700-$1.725 billion (previous range: $1.625-$1.675 billion), adjusted diluted earnings per share (EPS) in the range of $1.71-$1.76 (previous range: $1.55 to $1.60). According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $1.665 billion and EPS of $1.60 for fiscal 2013. 

Company Quote

22.14
-0.09 -0.40%
26 Nov 2014